Healthtech Solutions Inc. Sells Patents and World Reach Companies in $30 Million Deal with Papyrus
Healthtech Solutions Inc., a Utah-based corporation, has announced the completion of significant transactions involving the sale of its patent assets and corporate entities. On June 5, 2025, Healthtech Solutions entered into a Patent Purchase Agreement to sell one patent and four patent applications related to wound care products derived from placental membranes, including DermaBind-TL and DermaBind-FM, to Papyrus Therapeutic LLC for $5,000,000. Additionally, the company finalized the sale of its majority-owned World Reach Companies to Papyrus Distribution LLC for $25,000,000. The deal includes provisions for the payment of $10,000,000 through secured promissory notes. The transaction was completed on June 6, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthtech Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-25-004487), on June 13, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。